Biotech Patenting

Wednesday, March 14 to Thursday, March 15, 2012
Hotel Bayerischer Hof, Munich

In a rapidly shifting legal environment for the pharma industry, it has become crucial that biotech companies seek the most practical and competitive strategies for obtaining, extending and protecting their patent portfolios. The 2012 Munich Biotech Patenting forum will focus on latest legal developments affecting biotech companies, with a particular focus on successful techniques and strategies for drafting and filing patent applications in multiple jurisdictions. The event will provide a unique opportunity for you to network with your fellow industry peers, key industry regulators and expert patent attorneys from across globe, allowing you to develop your current biotech practices and remain competitive in today’s ever-changing and ever-expanding market.
C5’s 22nd Forum on Biotech Patenting brings together experienced in-house counsel from both innovator and generic pharma and biotech companies and their expert legal advisors from various jurisdictions across the globe. Based on their personal experience, the expert panel will lead you through invaluable, practical, and in-depth sessions on:

  • Determining How the G2/10 Decision will Change Biotech Disclaimer Practice Across Europe
  • Adopting New Patenting and Marketing Strategies to Overcome the Challenges of Filing your SPC Applications at an Earlier Stage
  • Navigating Around the Patentability of Stem Cells Through Strategic Claim Drafting
  • Case law developments in double patenting: from an European and US perspective
  • Current Developments on Biotech Products and Patent Considerations for Bio-Deposits
  • Successful strategies for cross-border litigation
  • Managing Patents for Biosimilar Products and Understanding the Bolar Provisions in Europe
  • Tackling Diagnostic Methods and Personalised Medicines
  • Patentability of Gene Sequence Patents in Europe and the US


Plus maximise your time by attending the post-conference workshop on the 16th March:
Strategies for Claiming Commercial Products in your Biotech Patent Applications
Illustrating what the examiners are looking for by using examples of best practice approaches

ALSO new this year is our Focus Day on the 13 March 2012 in Munich:
US Patent Reform for European Life Science companies
Analyzing the impact of the America Invents Act on IP Owners in the Life Science Industry in Europe

This focused event will discuss the impact of the significant changes to the US patent system on life science companies and what they need to consider when enforcing and protecting their rights in the USA.
US and European legal and regulatory experts from and for the pharma and biotech industry will gather at this unique forum to provide an in-depth analysis of the regal, regulatory and business challenges and discuss the changes surrounding the America Invests Act and its impact on the life sciences industry.

Register to attend this practical focus day on the impact of the US patent reform on Tuesday, 13 March 2012 to ensure you are staying ahead of the game when enforcing and protecting your IP rights in the USA.

C5’s Biotech Patenting conference is the ONE place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today. Join us at the 22nd C5 Forum on Biotech Patenting for an unparalleled learning and networking opportunity!

You can’t afford to miss out, so book your place today with our easy ways to register:

1. PHONE our registration hotline on +44 (0)20 7878 6888 
2. FAX your details directly to 020 7878 6885
3. EMAIL your details directly to registrations@C5-Online.com 

For more information, please contact:
Speaking opportunities:
Sonja Ruetzel, C5
Tel: : +44 (0) 20 7878 6930

Business development opportunities:
Jo Menzer, C5
Tel: +44 (0) 20 7878 6978